Baxter director granted 1,811 common shares

McDonnell Michael R. reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 02/18/2026 - 04:06 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

McDonnell Michael R. reported acquisition or exercise transactions in this Form 4 filing.

Baxter International director Michael R. McDonnell reported receiving a grant of 1,811 shares of Baxter common stock. The shares were granted at a price of $0.0000 per share and are described as fully vested, subject to the applicable grant terms and conditions. Following this award, McDonnell holds 1,811 shares of Baxter common stock directly.

Insider Trade Summary

Grant/Award: 1,811 shares

Grant/Award 1 txn

Insider McDonnell Michael R.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $1 par value	1,811	$0.00	$0.00

Holdings After Transaction: Common Stock, $1 par value — 1,811 shares (Direct)

Footnotes (1)

1. F1. The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Baxter (BAX) director Michael R. McDonnell report in this Form 4 filing?

Michael R. McDonnell reported receiving a grant of 1,811 fully vested Baxter common shares. The award was reported at a price of $0.0000 per share and is subject to the terms and conditions of the applicable grant agreement.

How many Baxter (BAX) shares did Michael R. McDonnell acquire in this transaction?

Michael R. McDonnell acquired 1,811 shares of Baxter common stock in this transaction. These shares were granted as fully vested stock and increased his directly held position to a total of 1,811 Baxter shares following the award.

Was the Baxter (BAX) stock grant to Michael R. McDonnell immediately vested?

Yes, the grant to Michael R. McDonnell consists of fully vested Baxter common shares. The filing notes that the shares are subject to the terms and conditions of the applicable grant but are described specifically as fully vested at the time of the award.

What was the reported price per share for Michael R. McDonnell’s Baxter (BAX) stock grant?

The reported price per share for the Baxter stock grant to Michael R. McDonnell was $0.0000. This indicates the shares were granted as compensation rather than purchased on the open market, consistent with a typical equity award to a company director.

Does Michael R. McDonnell hold Baxter (BAX) shares directly after this Form 4 transaction?

Yes, Michael R. McDonnell holds Baxter shares directly after this transaction. The Form 4 shows total shares following the transaction of 1,811, with ownership coded as direct, reflecting his personal holding of Baxter common stock after the grant.

What type of transaction does the Form 4 for Baxter (BAX) classify for Michael R. McDonnell?

The Form 4 classifies this as a grant, award, or other acquisition transaction. It uses transaction code “A,” indicating an acquisition of 1,811 non-derivative Baxter common shares as part of McDonnell’s director compensation arrangement with the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McDonnell Michael R.

(Last) (First) (Middle)

ONE BAXTER PARKWAY

(Street)

DEERFIELD IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BAXTER INTERNATIONAL INC [ BAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $1 par value	02/13/2026		A		1,811(1)	A	$0	1,811	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

Remarks:

	/s/ David S. Rosenbloom, as attorney in-fact for Michael R. McDonnell	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.